DXDISCOVERY, INC.

Basic Information

Applied Research Facilty MS 328
RENO, NV, 89557-0001

http://www.dxdiscovery.com

Company Profile

n/a

Additional Details

Field Value
DUNS: 78634704
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 5


  1. Point-of-care immunoassay for early diagnosis of pertussis

    Amount: $589,866.00

    DESCRIPTION (provided by applicant): Pertussis is a serious and potentially life-threatening respiratory disease caused by the bacterium Bordetella pertussis. Worldwide, 18.4 million people become ill ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Identification of Borrelia burgdorferi diagnostic biomarkers in humans and nonhum

    Amount: $591,671.00

    DESCRIPTION (provided by applicant): The number of Lyme disease cases in the US has been recently estimated by the CDC at 300,000 cases/year. This is major public health concern. Currently available d ...

    STTR Phase I 2014 Department of Health and Human Services
  3. High-affinity monoclonal antibodies that target Burkholderia Polysaccharide

    Amount: $149,751.00

    Melioidosis and glanders are life-threatening illnesses caused by the bacteria Burkholderia pseudomallei and Burkholderia mallei, respectively. These gram-negative bacilli are endemic to Northern Aust ...

    SBIR Phase I 2014 Department of DefenseOffice for Chemical and Biological DefenseDepartment of Defense
  4. Biomarker discovery for immunodiagnosis of invasive candidiasis

    Amount: $600,000.00

    DESCRIPTION (provided by applicant): Invasive candidiasis (IC) is one of the most serious threats to patients in a critical setting. With as many as 60,000 cases per year in the U.S., the total cost a ...

    STTR Phase I 2013 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government